ATE526984T1 - Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen - Google Patents

Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen

Info

Publication number
ATE526984T1
ATE526984T1 AT09710204T AT09710204T ATE526984T1 AT E526984 T1 ATE526984 T1 AT E526984T1 AT 09710204 T AT09710204 T AT 09710204T AT 09710204 T AT09710204 T AT 09710204T AT E526984 T1 ATE526984 T1 AT E526984T1
Authority
AT
Austria
Prior art keywords
bone morphogenetic
neuroblastomas
prevention
treatment
morphogenetic proteins
Prior art date
Application number
AT09710204T
Other languages
English (en)
Inventor
Hedwig Deubzer
Olaf Witt
Original Assignee
Dkfz Krebsforschungszentrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dkfz Krebsforschungszentrum filed Critical Dkfz Krebsforschungszentrum
Application granted granted Critical
Publication of ATE526984T1 publication Critical patent/ATE526984T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT09710204T 2008-02-13 2009-02-04 Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen ATE526984T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2837108P 2008-02-13 2008-02-13
PCT/EP2009/051258 WO2009101012A1 (en) 2008-02-13 2009-02-04 Methods for treating and preventing brain tumors based on bone morphogenetic proteins

Publications (1)

Publication Number Publication Date
ATE526984T1 true ATE526984T1 (de) 2011-10-15

Family

ID=40521521

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09710204T ATE526984T1 (de) 2008-02-13 2009-02-04 Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen

Country Status (4)

Country Link
US (1) US8361955B2 (de)
EP (1) EP2259792B1 (de)
AT (1) ATE526984T1 (de)
WO (1) WO2009101012A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014059279A2 (en) * 2012-10-13 2014-04-17 The University Of Toledo Materials and methods useful to treat neuroblastomas and pheochromocytomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949505B1 (en) 1991-03-11 2005-09-27 Curis, Inc. Morphogen-induced dendritic growth
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
CA2615491C (en) * 2005-07-19 2016-11-29 Stemgen S.P.A. Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps

Also Published As

Publication number Publication date
EP2259792A1 (de) 2010-12-15
US8361955B2 (en) 2013-01-29
WO2009101012A1 (en) 2009-08-20
EP2259792B1 (de) 2011-10-05
US20110020334A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA200971053A1 (ru) Способы лечения кожных язв
MX2010006519A (es) Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina.
MY140132A (en) Thiazolidin-4-one derivatives for use in the treatment of anemias
MX2010008206A (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf.
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
EA201000865A1 (ru) Комбинация ингибиторов протеинтирозинфосфатазы и гормона роста человека, предназначенная для лечения атрофии мышц и родственных нарушений
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
EA201000603A1 (ru) ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
MX2010001145A (es) Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
EA200600921A1 (ru) Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний
ATE385807T1 (de) Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug
DE602004021847D1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
ATE456955T1 (de) Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
EP4188410A4 (de) Chimäre proteine und verfahren zur verwendung zur behandlung von erkrankungen des zentralen nervensystems
ATE515268T1 (de) Verwendung von op-1 zur behandlung von knorpeldefekten
ZA202002107B (en) Use of specific sirna against protein s for the treatment of hemophilia
EP4241768A4 (de) Zusammensetzung zur behandlung von gefässerkrankungen, zusammensetzung zur prävention von gefässerkrankungen, zusammensetzung zur behandlung von bluthochdruck und zusammensetzung zur prävention von bluthochdruck
ATE526984T1 (de) Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties